Kronos Bio, Inc. (KRON) Financials

Stock symbol KRON is outdated, potentially delisted? Maybe it is available on other exchange?

KRON Assets vs Liabilities

Date	Assets	Liabilities
March 31, 2025	108.1 million	28.3 million
Dec. 31, 2024	124.4 million	36.8 million
Sept. 30, 2024	150.0 million	38.9 million
June 30, 2024	164.3 million	41.1 million

KRON Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
March 31, 2025	-12.8 million	140000
Dec. 31, 2024	-12.8 million	1.7 million
Sept. 30, 2024	-12.4 million	2.0 million
June 30, 2024	-16.3 million	2.2 million

KRON Net Income

No data available :(

KRON Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
March 31, 2025	99.7 million	20.4 million	24.1 million
Dec. 31, 2024	112.4 million	21.5 million	21.5 million
Sept. 30, 2024	124.9 million	22.5 million	25.8 million
June 30, 2024	136.6 million	23.5 million	27.1 million

KRON Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
March 31, 2025	60.3 million
Dec. 31, 2024	60.3 million
Sept. 30, 2024	60.3 million
June 30, 2024	60.1 million

KRON Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
March 31, 2025	4000	2.1 million	6.1 million	-
Dec. 31, 2024	4000	8.4 million	4.9 million	-
Sept. 30, 2024	7000	12.3 million	5.8 million	-
June 30, 2024	-	13.8 million	6.4 million	1.2 million

KRON Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
March 31, 2025	1.9 million	409000
Dec. 31, 2024	2.3 million	-
Sept. 30, 2024	2.4 million	-
June 30, 2024	2.7 million	420000

KRON

Price: $0.88

52 week price:

0.65

1.60

Earnings Per Share: -1.07 USD

P/E Ratio: -0.64

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 184700

Market Capitalization: 41.5 million

Links:

KRON on Yahoo Finance